-
Featured
Sex-specific Genetic Effects Across Neuropsychiatric and Behavioral Traits Identified for the First Time
Jill M. Goldstein, PhD, and Jordan W. Smoller, MD, ScD, of the Department of Psychiatry, and colleagues have reported the first modest evidence of sex-dependent autosomal genetic effects across neuropsychiatric and behavioral traits.
-
Featured
Longitudinal Data in Electronic Health Records Can Be Used to Predict Risk of Suicide
Previous research has shown that diagnostic codes routinely collected in electronic health records can help predict domestic abuse an average of two years in advance. Could EHR systems also be used to predict suicidal behavior?
-
Mass General Researchers Find Esmethadone Effective For Major Depressive Disorder
Led by Maurizio Fava, MD, a team of Massachusetts General Hospital researchers have discovered that esmethadone produces favorable outcomes for patients diagnosed with major depressive disorder who previously experienced inadequate responses to antidepressant treatments.
-
Consensus Statement: Conducting Digital Monitoring Studies of People at Suicide Risk
Matthew K. Nock, PhD, of the Department of Psychiatry, and colleagues have published a consensus statement about best practices for conducting real-time digital monitoring studies of people at risk of suicide and related behaviors.
-
Pilot: Mind–Body Interventions Enhance Coping by Patients with Paroxysmal Atrial Fibrillation
Massachusetts General Hospital researchers found in a pilot randomized, waitlist-controlled trial that the SMART Program (an eight-week group-based, virtually delivered mind–body intervention) improved quality of life, and stress reactivity/coping, and had positive effects in paroxysmal atrial fibrillation patients.
-
COVID-19 May Cause a Distinct Type of Major Depression
Roy H. Perlis, MD, MSc, of the Department of Psychiatry, and colleagues compared features of major depressive disorder in individuals with or without prior COVID-19. They found indirect evidence that symptoms are a sequela of COVID-19 pathophysiology in a subset of individuals.
Psychiatry Contributors
-
David Mischoulon, MD, PhD
Director, Depression Clinical and Research Program
Recent Article
Mindfulness-based Cognitive Therapy Shows Promise for Treating Depression in Chronically Ill Patients
-
Eve Valera, PhD
Researcher, Athinoula A. Martinos Center for Biomedical Imaging
Recent Article
Traumatic Brain Injuries Caused by Intimate Partner Violence
-
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Recent Article
Portable Imaging Test Shows Promise for Detection of Cannabis Intoxication
-
Jordan W. Smoller, MD, ScD
Associate Chief for Research, Department of Psychiatry, Massachusetts General Hospital, Director, Psychiatric and Neurodevelopmental Genetics Unit, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health
Recent Article
Sex-specific Genetic Effects Across Neuropsychiatric and Behavioral Traits Identified for the First Time
-
Maurizio Fava, MD
Psychiatrist-In-Chief; Director, Division of Clinical Research of the MGH Research Institute, Executive Director, Clinical Trials Network and Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Recent Article
Mass General Researchers Find Esmethadone Effective For Major Depressive Disorder
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
